Autoimmune polyendocrine syndrome historical perspective

Jump to navigation Jump to search

Autoimmune polyendocrine syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune polyendocrine syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune polyendocrine syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune polyendocrine syndrome historical perspective

CDC on Autoimmune polyendocrine syndrome historical perspective

Autoimmune polyendocrine syndrome historical perspective in the news

Blogs on Autoimmune polyendocrine syndrome historical perspective

Directions to Hospitals Treating Autoimmune polyendocrine syndrome

Risk calculators and risk factors for Autoimmune polyendocrine syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

In 19th century physicians first focussed their attention on constellation of symptoms associated with autoimmune polyendocrine syndrome. In 1855, Thomas Addison identified patients with Addison's disease who also appeared to have coexisting pernicious anemia. In 1956, Roitt and Doniach found that patients with Hashimoto's thyroiditis had circulating autoantibodies reacting with thyroid gland. In 1964, Carpenter described the association between adrenocortical failure, thyroiditis and insulin-dependent diabetes mellitus. In 1980, Neufeld and Blizzard first developed the classification for polyglandular failure and in 1982 categorized autoimmune polyendocrine syndrome into type 1 and type 2.

Historical Perspective

The history associated with autoimmune polyendocrine syndrome is as below:[1][2][3][4][5]

References

  1. SOLOMAN N, CARPENTER CJ, BENNETT IL, HARVEY AM (1965). "SCHMIDT'S SYNDROME (THYROID AND ADRENAL INSUFFICIENCY) AND COEXISTENT DIABETES MELLITUS". Diabetes. 14: 300–4. PMID 14280372.
  2. Khalid, Nauman; Chhabra, Lovely; Ahmad, Sarah Aftab; Umer, Affan; Spodick, David H. (2015). "Autoimmune Polyglandular Syndrome Type 2 Complicated by Acute Adrenal Crisis and Pericardial Tamponade in the Setting of Normal Thyroid Function". Methodist DeBakey Cardiovascular Journal. 11 (4): 250–252. doi:10.14797/mdcj-11-4-250. ISSN 1947-6094.
  3. Bottazzo GF, Florin-Christensen A, Doniach D (1974). "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies". Lancet. 2 (7892): 1279–83. PMID 4139522.
  4. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002). "Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction". Endocr. Rev. 23 (3): 327–64. doi:10.1210/edrv.23.3.0466. PMID 12050123.
  5. "[POLYENDOCRINE insufficiency with normal hypophysis; Claude and Gougerot syndrome; primary panhypotelendocrinosis]". Annee Endocrinol (in French). 11: 198–201. 1959. PMID 13856661.

Template:WH Template:WS